A randomized, placebo controlled trial comparing the efficacy of a combination of oral 5mg finasteride and 5% minoxidil solution versus 5%minoxidil alone in treatment of female pattern hair loss (FPHL) in post- menopausal women.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20170919003

Enrollment

Registered

2017-09-19

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female pattern hair loss Androgenetic alopecia Female pattern hair loss Finasteride Post&#45

Interventions

finasteride 5 mg oral per day plus minoxidil 5% topical twice a day for 24 weeks,minoxidil 5% topical twice a day fore 24 weeks

Experimental Drug,Active Comparator Drug

finasteride ,control

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female age 18-60 Menopause History, clinical and dermoscope showed Ludwig classification I-4,II-1,II-2,frontal type

Exclusion criteria

Exclusion criteria: family history of breast cancer, thyroid disease, iron deficiency anemia, pregnancy, psychiatric problem, previous treatment with laser or medication within 3 months. previous hair transplant within 1 year

Design outcomes

Primary

Measure	Time frame
hair density at 24 weeks after start intervention hair density(non-vellus hair) at midscalp by FotofinderÂ®	—

Secondary

Measure	Time frame
photographic assessment score at 24 weeks after start intervention photographic assessment questionaire,hair mass index at midscalp at start and 24 weeks after start intervention HairCheckÂ® ,severity of female androgenetic alopecia at start and 24 weeks after start intervention Ludwig classification ,Satisfaction score at start and 24 weeks after start intervention patient self-assessment questionnaires,side effect 4 weeks after start intervention questionare	—

Measure

Time frame

photographic assessment score at 24 weeks after start intervention photographic assessment questionaire,hair mass index at midscalp at start and 24 weeks after start intervention HairCheckÂ® ,severity of female androgenetic alopecia at start and 24 weeks after start intervention Ludwig classification ,Satisfaction score at start and 24 weeks after start intervention patient self-assessment questionnaires,side effect 4 weeks after start intervention questionare

—

Countries

thailand

Contacts

Public Contactratchathorn chanprateep

King Chulalongkorn Memorial Hospital

Rpanchaprateep@gmail.com0898923819

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

A randomized&#44; placebo controlled trial comparing the efficacy of a combination of oral 5mg finasteride and 5% minoxidil solution versus 5%minoxidil alone in treatment of female pattern hair loss (FPHL) in post&#45; menopausal women.

Conditions

Related papers

Interventions

Sponsors

Eligibility

Inclusion criteria

Exclusion criteria

Design outcomes

Primary

Secondary

Countries

Contacts

Outcome results

A randomized, placebo controlled trial comparing the efficacy of a combination of oral 5mg finasteride and 5% minoxidil solution versus 5%minoxidil alone in treatment of female pattern hair loss (FPHL) in post- menopausal women.